Nikaido H, Liu W, Rosenberg E Y
Department of Molecular and Cell Biology, University of California, Berkeley 94720.
Antimicrob Agents Chemother. 1990 Feb;34(2):337-42. doi: 10.1128/AAC.34.2.337.
Some enteric bacteria, such as Enterobacter cloacae, can develop high-level resistance to broad-spectrum cephalosporins by overproducing their chromosomally encoded type I beta-lactamases. This is because these agents are hydrolyzed rapidly at pharmacologically relevant, low (0.1 to 1 microM), concentrations, owing to their high affinity for type I enzymes. In contrast, the more recently developed cephalosporins, with quaternary-nitrogen-containing substituents at the 3 position, show increased efficacy against beta-lactamase-overproducing strains and, indeed, have a much lower affinity for type I enzymes. However, the possible contribution of an improved outer membrane permeability in their increased efficacy has not been studied. We found by proteoliposome swelling assays that cefepime, cefpirome, and E-1040 all penetrated the porin channels of Escherichia coli and E. cloacae much more rapidly than did ceftazidime and at least as rapidly as did cefotaxime. Considering that the influx of anionic compounds such as cefotaxime and ceftazidime will be further retarded in intact cells, owing to the Donnan potential, we expect that the newer compounds will penetrate intact cells 2 to 10 times more rapidly than will cefotaxime and ceftazidime. The kinetic parameters of hydrolysis of these agents by E. cloacae beta-lactamase showed that at 0.1 microM, they were hydrolyzed much more slowly than was cefotaxime and at about the same rate as or a lower rate than was ceftazidime. The combination of these two effects explains nearly quantitatively why these newer agents are more effective against some of the beta-lactamase-overproducing gram-negative bacteria.
一些肠道细菌,如阴沟肠杆菌,可通过过量产生其染色体编码的I型β-内酰胺酶而对广谱头孢菌素产生高水平耐药性。这是因为这些药物在药理学相关的低浓度(0.1至1 microM)下会迅速被水解,这是由于它们对I型酶具有高亲和力。相比之下,最近开发的在3位带有含季氮取代基的头孢菌素,对β-内酰胺酶过量产生的菌株显示出更高的疗效,并且实际上对I型酶的亲和力要低得多。然而,其外膜通透性改善在提高疗效方面的可能作用尚未得到研究。我们通过蛋白脂质体肿胀试验发现,头孢吡肟、头孢匹罗和E-1040穿透大肠杆菌和阴沟肠杆菌孔蛋白通道的速度比头孢他啶快得多,且至少与头孢噻肟一样快。考虑到由于唐南电位,完整细胞中头孢噻肟和头孢他啶等阴离子化合物的流入会进一步受阻,我们预计新化合物穿透完整细胞的速度将比头孢噻肟和头孢他啶快2至10倍。阴沟肠杆菌β-内酰胺酶对这些药物水解的动力学参数表明,在0.1 microM时,它们的水解速度比头孢噻肟慢得多,且与头孢他啶的水解速度大致相同或更低。这两种作用的结合几乎定量地解释了为什么这些新药物对一些β-内酰胺酶过量产生的革兰氏阴性菌更有效。